Performance Review Board Members, 74806 [2016-26023]
Download as PDF
<![CDATA[
74806
Federal Register / Vol. 81, No. 208 / Thursday, October 27, 2016 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–26019 Filed 10–26–16; 8:45 am]
National Vaccine Injury Compensation
Program; List of Petitions Received
BILLING CODE 4163–18–P
Health Resources and Services
Administration
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Performance Review Board Members
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) located
within the Department of Health and
Human Services (HHS) is publishing the
names of the Performance Review Board
Members who are reviewing
performance for Fiscal Year 2016.
FOR FURTHER INFORMATION CONTACT:
Sharon O’Brien, Deputy Director,
Executive and Scientific Resources
Office, Human Resources Office, Centers
for Disease Control and Prevention,
4770 Buford Highway NE., Mailstop K–
15, Atlanta, Georgia 30341, Telephone
(770) 488–1781.
SUPPLEMENTARY INFORMATION: Title 5,
U.S.C. Section 4314(c) (4) of the Civil
Service Reform Act of 1978, Public Law
95–454, requires that the appointment
of Performance Review Board Members
be published in the Federal Register.
The following persons will serve on the
CDC Performance Review Boards or
Panels, which will oversee the
evaluation of performance appraisals of
Senior Executive Service members for
the Fiscal Year 2016 review period:
Branche, Christine, Co-Chair
Seligman, James, Co-Chair
Arispe, Irma
Curlee, Robert
Dean, Hazel
Henderson, Joseph
Kotch, Alan
Kosmos, Christine
Qualters, Judith
Shelton, Dana
Smagh, Kevin
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
Dated: October 24, 2016.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2016–26023 Filed 10–26–16; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:43 Oct 26, 2016
Jkt 241001
HRSA is publishing this
notice of petitions received under the
National Vaccine Injury Compensation
Program (the Program), as required by
Section 2112(b)(2) of the Public Health
Service (PHS) Act, as amended. While
the Secretary of HHS is named as the
respondent in all proceedings brought
by the filing of petitions for
compensation under the Program, the
United States Court of Federal Claims is
charged by statute with responsibility
for considering and acting upon the
petitions.
FOR FURTHER INFORMATION CONTACT: For
information about requirements for
filing petitions, and the Program in
general, contact the Clerk, United States
Court of Federal Claims, 717 Madison
Place NW., Washington, DC 20005,
(202) 357–6400. For information on
HRSA’s role in the Program, contact the
Director, National Vaccine Injury
Compensation Program, 5600 Fishers
Lane, Room 08N146B, Rockville, MD
20857; (301) 443–6593, or visit our Web
site at: https://www.hrsa.gov/
vaccinecompensation/.
SUPPLEMENTARY INFORMATION: The
Program provides a system of no-fault
compensation for certain individuals
who have been injured by specified
childhood vaccines. Subtitle 2 of Title
XXI of the PHS Act, 42 U.S.C. 300aa–
10 et seq., provides that those seeking
compensation are to file a petition with
the U.S. Court of Federal Claims and to
serve a copy of the petition on the
Secretary of Health and Human
Services, who is named as the
respondent in each proceeding. The
Secretary has delegated this
responsibility under the Program to
HRSA. The Court is directed by statute
to appoint special masters who take
evidence, conduct hearings as
appropriate, and make initial decisions
as to eligibility for, and amount of,
compensation.
A petition may be filed with respect
to injuries, disabilities, illnesses,
conditions, and deaths resulting from
vaccines described in the Vaccine Injury
Table (the Table) set forth at 42 CFR
100.3. This Table lists for each covered
SUMMARY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
childhood vaccine the conditions that
may lead to compensation and, for each
condition, the time period for
occurrence of the first symptom or
manifestation of onset or of significant
aggravation after vaccine
administration. Compensation may also
be awarded for conditions not listed in
the Table and for conditions that are
manifested outside the time periods
specified in the Table, but only if the
petitioner shows that the condition was
caused by one of the listed vaccines.
Section 2112(b)(2) of the PHS Act, 42
U.S.C. 300aa–12(b)(2), requires that
‘‘[w]ithin 30 days after the Secretary
receives service of any petition filed
under section 2111 the Secretary shall
publish notice of such petition in the
Federal Register.’’ Set forth below is a
list of petitions received by HRSA on
September 1, 2016, through September
30, 2016. This list provides the name of
petitioner, city and state of vaccination
(if unknown then city and state of
person or attorney filing claim), and
case number. In cases where the Court
has redacted the name of a petitioner
and/or the case number, the list reflects
such redaction.
Section 2112(b)(2) also provides that
the special master ‘‘shall afford all
interested persons an opportunity to
submit relevant, written information’’
relating to the following:
1. The existence of evidence ‘‘that
there is not a preponderance of the
evidence that the illness, disability,
injury, condition, or death described in
the petition is due to factors unrelated
to the administration of the vaccine
described in the petition,’’ and
2. Any allegation in a petition that the
petitioner either:
a. ‘‘[S]ustained, or had significantly
aggravated, any illness, disability,
injury, or condition not set forth in the
Vaccine Injury Table but which was
caused by’’ one of the vaccines referred
to in the Table, or
b. ‘‘[S]ustained, or had significantly
aggravated, any illness, disability,
injury, or condition set forth in the
Vaccine Injury Table the first symptom
or manifestation of the onset or
significant aggravation of which did not
occur within the time period set forth in
the Table but which was caused by a
vaccine’’ referred to in the Table.
In accordance with Section
2112(b)(2), all interested persons may
submit written information relevant to
the issues described above in the case of
the petitions listed below. Any person
choosing to do so should file an original
and three (3) copies of the information
with the Clerk of the U.S. Court of
Federal Claims at the address listed
above (under the heading FOR FURTHER
E:\FR\FM\27OCN1.SGM
27OCN1
]]>Agencies
[Federal Register Volume 81, Number 208 (Thursday, October 27, 2016)]
[Notices]
[Page 74806]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26023]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Performance Review Board Members
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) located
within the Department of Health and Human Services (HHS) is publishing
the names of the Performance Review Board Members who are reviewing
performance for Fiscal Year 2016.
FOR FURTHER INFORMATION CONTACT: Sharon O'Brien, Deputy Director,
Executive and Scientific Resources Office, Human Resources Office,
Centers for Disease Control and Prevention, 4770 Buford Highway NE.,
Mailstop K-15, Atlanta, Georgia 30341, Telephone (770) 488-1781.
SUPPLEMENTARY INFORMATION: Title 5, U.S.C. Section 4314(c) (4) of the
Civil Service Reform Act of 1978, Public Law 95-454, requires that the
appointment of Performance Review Board Members be published in the
Federal Register. The following persons will serve on the CDC
Performance Review Boards or Panels, which will oversee the evaluation
of performance appraisals of Senior Executive Service members for the
Fiscal Year 2016 review period:
Branche, Christine, Co-Chair
Seligman, James, Co-Chair
Arispe, Irma
Curlee, Robert
Dean, Hazel
Henderson, Joseph
Kotch, Alan
Kosmos, Christine
Qualters, Judith
Shelton, Dana
Smagh, Kevin
Dated: October 24, 2016.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2016-26023 Filed 10-26-16; 8:45 am]
BILLING CODE 4163-18-P
